Epilepsy Studies

If you think you may qualify for one of these studies, please contact CNI’s Research Department at 303-806-7423.

ESL: A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

The objective of this research trial is to evaluate the effectiveness of a study drug  administered once daily as the first or later adjunctive therapy based on  the number of seizures reported over a 24-week maintenance period.

Eligibility and information – Opening soon to enrollment
Principal Investigator: Charles Livsey, MD, PhD
Research Coordinator: Tyler Irani (720.975.0013)


YKP: Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

 The objective of this study is to evaluate the safety and blood concentration and activity of YKP3089 (study drug) and other anti-epileptic drugs (AEDs) when taken together to treat partial onset seizures.

Eligibility and information – Closed to enrollment
Principal Investigator: Charles Livsey, MD, PhD

 

 

 

 

Colorado Neurological Insitute